Welcome to our dedicated page for International Business Machines SEC filings (Ticker: IBM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for International Business Machines Corporation (IBM) provides access to the company’s regulatory disclosures as a New York–incorporated issuer with capital stock listed on the New York Stock Exchange under the symbol IBM. These documents help investors understand IBM’s financial condition, capital structure, credit arrangements and material events.
IBM’s filings include current reports on Form 8‑K that cover topics such as quarterly earnings announcements, prepared remarks and presentation slides for investor calls, and amendments to significant credit agreements. For example, IBM has reported quarterly results for periods ended June 30 and September 30, 2025, and disclosed amendments extending the maturities of its three‑year and five‑year credit agreements. Form 8‑K filings also list the company’s registered notes and debentures, showing the range of debt securities traded on the New York Stock Exchange alongside IBM’s common stock.
The filings set out details on IBM’s various series of notes and debentures, including instruments due in years ranging from 2025 to 2096. Separate Form 25 filings document the removal from listing of specific debt securities, such as certain notes and debentures due in 2025, while the common stock remains listed. Together, these records give a view of IBM’s financing activities and the lifecycle of individual securities.
On this page, Stock Titan pairs real-time updates from the SEC’s EDGAR system with AI-powered summaries that explain the purpose and key points of each filing in clear language. Investors can quickly review current reports on Form 8‑K, track changes to credit facilities, and see when particular notes or debentures are removed from listing via Form 25 notifications, without reading every technical detail themselves.
Michelle J. Howard, a director of International Business Machines Corp. (IBM), received 292 shares of common stock as Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. The transaction, recorded 09/30/2025, shows the shares were issued at a per-share value of $282.16 and increased her total beneficial ownership to 15,580 shares. The filing explains these Promised Fee Shares represent deferred director fees that are payable after retirement and remain deferred until retirement under the plan.
Alex Gorsky, an IBM director, reported a non‑derivative acquisition on 09/30/2025 involving 381 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. Those shares were recorded at a per‑share value of $282.16. Following the transaction, Gorsky beneficially owns 32,805 shares of IBM common stock on a direct basis. The filing notes the shares are part of a deferred compensation arrangement and that distribution of the Promised Fee Shares is deferred until retirement. This Form 4 reflects a routine fee deferral by a director rather than an open‑market purchase or sale.
Marianne C. Brown, a director of International Business Machines Corp (IBM), reported a non-derivative acquisition related to deferred director fees. The Form 4 shows a transaction dated 09/30/2025 in which 324 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan were recorded as acquired at a stated fee/share price of $282.16. Those Promised Fee Shares are payable after retirement and are deferred until retirement. Following this reported transaction, Ms. Brown beneficially owns 2,947 shares of IBM common stock in a direct ownership form. The filing was executed on 10/01/2025.
Reporting person Nicolas A. Fehring, Vice President and Controller of International Business Machines Corporation (IBM), filed a Form 4 reporting transactions on September 1-2, 2025. The filing shows vested restricted stock units (RSUs) and related share movements: 2,742 RSUs were released and converted to 2,742 shares on 09/01/2025, a sale of 1,388 shares at $243.59 on 09/01/2025, and a disposition of 400 shares on 09/02/2025.
After these transactions the reporting person beneficially owned 13,735.419 shares. The Form 4 explains the RSU grant history (original grant on 09/01/2021 with vesting tranches) and notes certain RSUs are payable in cash or common stock with future vesting dates.